Showing results (2421-2430 of 6,717) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|July 20, 2018
Overexpression of DJ-1 correlates with aggressive clinicopathological characteristics and poor prognosis in malignant tumors: a meta-analysisQingting Wang, Fangwei Li, Wenhua Shi, et al.
Oncotargets and Therapy|July 20, 2018
Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP-2 and -9 in endometrial polyps and endometrial cancer type IGustavo Filipov Peres, Daniel Spadoto-Dias, Flávia Neves Bueloni-Dias, et al.
Oncotargets and Therapy|July 20, 2018
SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasionHongjie Sun, Dongli Huang, Guozheng Liu, et al.
Oncotargets and Therapy|May 30, 2017
Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapyLi Chen, Yanjiao Zuo, Lihua Zhu, et al.
Oncotargets and Therapy|May 30, 2017
Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective studyYi Sun, Yong Wang, Shaolong Han, et al.
Oncotargets and Therapy|June 3, 2017
The novel long noncoding RNA RP11-357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancerBiao Yang, Tianhang Luo, Meijing Zhang, et al.
Oncotargets and Therapy|June 6, 2017
Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutationXue-Lian Pang, Qiao-Xin Li, Zhi-Ping Ma, et al.
Oncotargets and Therapy|May 17, 2017
Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatmentYingyun Shi, Renbing Jia, Xianqun Fan
Oncotargets and Therapy|April 27, 2017
Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapyQiqi Liu, Pingping Hu, Guodong Deng, et al.
Oncotargets and Therapy|April 26, 2018
IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancerYunxia Zhang, Jing Wang, Di Wu, et al.
Pageof 672